Oenin

Oenin

SCHEMBL723403

COc1cc(-c2[o+]c3cc(O)cc(O)c3cc2O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)cc(OC)c1O.[Cl-]

nearest known ligand 0.73

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Oenin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 1/20 0.45
CD38 P28907 3/20 0.73
DPP4 P27487 2/20 0.73
F2 P00734 1/20 0.65
MAOA P21397 1/20 0.58
TYR P14679 1/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
SLC28A3 Q9HAS3 2/20 0.48
ALDH1A1 P00352 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA7 P43166 1/20 0.47
CA9 Q16790 1/20 0.47
CA13 Q8N1Q1 1/20 0.47
EPHX2 P34913 2/20 0.47
POLB P06746 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oenin SCHEMBL1096836 1.00 CD38 (0.73) CD38DPP4F2MAOATYR
Oenin SCHEMBL29881103 1.00 CD38 (0.73) CD38DPP4F2MAOATYR
Oenin SCHEMBL29521448 0.99 CD38 (0.74) CD38DPP4F2MAOATYR
Oenin SCHEMBL676018 0.99 CD38 (0.74) CD38DPP4F2MAOATYR
Oenin SCHEMBL662772 0.99 CD38 (0.74) CD38DPP4F2MAOATYR
Oenin SCHEMBL6139047 0.99 CD38 (0.74) CD38DPP4F2MAOATYR
Oenin SCHEMBL29894980 0.99 CD38 (0.74) CD38DPP4F2MAOATYR
Oenin SCHEMBL29468973 0.99 CD38 (0.74) CD38DPP4F2MAOATYR
Hydrochloric Acid SCHEMBL29894492 0.98 CD38 (0.73) CD38DPP4F2MAOATYR
Hydrochloric Acid SCHEMBL30437834 0.98 CD38 (0.73) CD38DPP4F2MAOATYR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118914413-A Ultra-high performance liquid chromatography-tandem mass spectrometry method for simultaneously detecting 39 kinds of anthocyanin in litchi 海南省农业科学院三亚研究院(海南省实验动物研究中心) 2024-11-08 CN claimed
CN-118914413-B Ultra-high performance liquid chromatography-tandem mass spectrometry method for simultaneously detecting 39 kinds of anthocyanin in litchi 海南省农业科学院三亚研究院(海南省实验动物研究中心) 2024-12-03 CN disclosed
CN-118914413-A Ultra-high performance liquid chromatography-tandem mass spectrometry method for simultaneously detecting 39 kinds of anthocyanin in litchi 海南省农业科学院三亚研究院(海南省实验动物研究中心) 2024-11-08 CN disclosed
CN-115612114-B Copolymer membrane and method for enzymatic self-assembly synthesis and application thereof 中国科学院天津工业生物技术研究所 2024-02-20 CN disclosed
CN-115612403-B Self-assembled strong-adhesion copolymer film, coating method and application 中国科学院天津工业生物技术研究所 2023-12-01 CN disclosed
WO-2023284777-A1 COPOLYMER FILM, ENZYME CATALYSIS SELF-ASSEMBLY SYNTHESIS METHOD THEREFOR, AND APPLICATION THEREOF 中国科学院天津工业生物技术研究所 2023-01-19 WO disclosed
CN-115612699-A Copolymer membrane and enzymatic self-assembly synthesis method and application thereof at gas-liquid interface 中国科学院天津工业生物技术研究所 2023-01-17 CN disclosed
CN-115612114-A Copolymer membrane and enzymatic self-assembly synthesis method and application thereof 中国科学院天津工业生物技术研究所 2023-01-17 CN disclosed
CN-115612403-A Self-assembly strong-adhesion copolymer film, film coating method and application 中国科学院天津工业生物技术研究所 2023-01-17 CN disclosed
US-10589003-B2 Methods for coating surfaces with antimicrobial agents THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2020-03-17 US disclosed
US-20180127687-A1 DETERGENTS WITH IMPROVED DETERGENT POWER, CONTAINING AT LEAST ONE LACCASE HENKEL AG & CO. KGAA (DE) 2018-05-10 US disclosed
EP-2609200-B1 FILAMENTOUS FUNGI HAVING AN ALTERED VISCOSITY PHENOTYPE DANISCO US INC (US) 2017-04-26 EP disclosed
US-20130224864-A1 FILAMENTOUS FUNGI HAVING AN ALTERED VISCOSITY PHENOTYPE DANISCO US INC. (US) 2013-08-29 US disclosed
EP-2609200-A1 FILAMENTOUS FUNGI HAVING AN ALTERED VISCOSITY PHENOTYPE Danisco US Inc. (US) 2013-07-03 EP disclosed
WO-2012027580-A1 FILAMENTOUS FUNGI HAVING AN ALTERED VISCOSITY PHENOTYPE DANISCO US INC. (US) 2012-03-01 WO disclosed
US-7713472-B2 Antiseptic derivatives with broad spectrum antimicrobial activity for the impregnation of surfaces BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2010-05-11 US disclosed
US-7651661-B2 Medical devices with broad spectrum antimicrobial activity BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2010-01-26 US disclosed
US-20080183152-A1 MEDICAL DEVICES WITH BROAD SPECTRUM ANTIMICROBIAL ACTIVITY RAAD ISSAM 2008-07-31 US disclosed
US-20070154621-A1 METHODS FOR COATING SURFACES WITH ANTIMICROBIAL AGENTS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2007-07-05 US disclosed
US-20050197634-A1 Methods for coating and impregnating medical devices with antiseptic compositions BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2005-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10589003-B2 Methods for coating surfaces with antimicrobial agents CUTA, CD63, CDC37 ACHE 808/4885CD38 618/4885DPP4 1604/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.